Principal Activity
Research and commercial development of treatments for liver cancer
Price | Change | Last updated |
---|---|---|
17.000 | 0.100 (0.59%) |
Open | 16.900 |
---|---|
High | 17.000 |
Low | 16.760 |
Prev close | 16.900 |
Vol | 99.9K |
Val ($A) | 1.6M |
Prev Close | 16.900 | Volume | 99,900 |
---|---|---|---|
Bid | 16.810 | Average Volume | 155,634 |
Ask | 17.000 | Value ($A) | 1,692,056 |
52-wk High | 17.610 | P/E | 43.93 |
52-wk Low | 10.780 | Div/Share | 0.1200 |
EPS | 0.39 | Div Yield | 0.7% |
Earnings Yield | 2.28% | Status | - |
Market Cap | 953,843,463 | Sector | Health Care (35) |
---|---|---|---|
Issued Shares | 56,108,439 | Industry Group | Pharmaceuticals, Biotechnology & Life Sciences (3520) |
First Listed | 24 Aug 2000 | Security Type | Ordinary (1) |
First Traded | 09 Aug 2000 |
Research and commercial development of treatments for liver cancer
Trades | Volume | Value | High | Low | |
---|---|---|---|---|---|
This Week | 10,088 | 860,178 | 14,377,586 | 17.150 | 16.000 |
This Month | 29,105 | 2,079,633 | 34,970,926 | 17.360 | 16.000 |
This Year | 264,256 | 21,676,018 | 333,732,318 | 17.610 | 11.350 |
Rolling Year | 483,690 | 46,938,868 | 647,805,604 | 17.610 | 10.780 |